- Home
- CCCC vs MFM Comparison
CCCC vs MFM Comparison
Compare CCCC & MFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- MFM
- Stock Information
- Founded
- CCCC 2015
- MFM 1986
- Country
- CCCC United States
- MFM United States
- Employees
- CCCC N/A
- MFM N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- MFM Finance Companies
- Sector
- CCCC Health Care
- MFM Finance
- Exchange
- CCCC Nasdaq
- MFM Nasdaq
- Market Cap
- CCCC 244.9M
- MFM 219.5M
- IPO Year
- CCCC 2020
- MFM N/A
- Fundamental
- Price
- CCCC $3.01
- MFM $5.51
- Analyst Decision
- CCCC Buy
- MFM
- Analyst Count
- CCCC 5
- MFM 0
- Target Price
- CCCC $11.60
- MFM N/A
- AVG Volume (30 Days)
- CCCC 1.8M
- MFM 108.1K
- Earning Date
- CCCC 03-04-2025
- MFM 01-01-0001
- Dividend Yield
- CCCC N/A
- MFM 4.08%
- EPS Growth
- CCCC N/A
- MFM N/A
- EPS
- CCCC N/A
- MFM 0.03
- Revenue
- CCCC $33,668,000.00
- MFM N/A
- Revenue This Year
- CCCC $75.59
- MFM N/A
- Revenue Next Year
- CCCC N/A
- MFM N/A
- P/E Ratio
- CCCC N/A
- MFM $176.67
- Revenue Growth
- CCCC 65.45
- MFM N/A
- 52 Week Low
- CCCC $2.79
- MFM $4.37
- 52 Week High
- CCCC $11.88
- MFM $5.48
- Technical
- Relative Strength Index (RSI)
- CCCC 33.55
- MFM 56.54
- Support Level
- CCCC $2.79
- MFM $5.43
- Resistance Level
- CCCC $3.38
- MFM $5.53
- Average True Range (ATR)
- CCCC 0.20
- MFM 0.06
- MACD
- CCCC -0.03
- MFM 0.00
- Stochastic Oscillator
- CCCC 23.66
- MFM 83.33
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
About MFM MFS Municipal Income Trust
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.